HUT77085A - Ösztradioltartalmú transzdermális terápiás rendszer TTS vízmegkötő adalékokkal és eljárás előállítására - Google Patents

Ösztradioltartalmú transzdermális terápiás rendszer TTS vízmegkötő adalékokkal és eljárás előállítására

Info

Publication number
HUT77085A
HUT77085A HU9701729A HU9701729A HUT77085A HU T77085 A HUT77085 A HU T77085A HU 9701729 A HU9701729 A HU 9701729A HU 9701729 A HU9701729 A HU 9701729A HU T77085 A HUT77085 A HU T77085A
Authority
HU
Hungary
Prior art keywords
pct
therapeutic system
transdermal therapeutic
oestradiol
production
Prior art date
Application number
HU9701729A
Other languages
English (en)
Other versions
HU226959B1 (en
Inventor
Michael Horstmann
Walter Müller
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh And Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Gmbh And Co. Kg filed Critical Lts Lohmann Therapie-Systeme Gmbh And Co. Kg
Publication of HUT77085A publication Critical patent/HUT77085A/hu
Publication of HU226959B1 publication Critical patent/HU226959B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
HU9701729A 1994-08-20 1995-08-12 Oestradiol containing transdermal therapeutic system (tts) comprising glycerin as hygroscopic additive HU226959B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4429667A DE4429667C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
PCT/EP1995/003201 WO1996005814A1 (de) 1994-08-20 1995-08-12 Estradiol-tts mit wasserbindenden zusätzen

Publications (2)

Publication Number Publication Date
HUT77085A true HUT77085A (hu) 1998-03-02
HU226959B1 HU226959B1 (en) 2010-03-29

Family

ID=6526231

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701729A HU226959B1 (en) 1994-08-20 1995-08-12 Oestradiol containing transdermal therapeutic system (tts) comprising glycerin as hygroscopic additive

Country Status (22)

Country Link
US (1) US5902602A (hu)
EP (1) EP0776199B1 (hu)
JP (1) JP3825799B2 (hu)
KR (1) KR100401136B1 (hu)
CN (1) CN1078461C (hu)
AT (1) ATE185067T1 (hu)
AU (1) AU695970B2 (hu)
CZ (1) CZ289397B6 (hu)
DE (2) DE4429667C2 (hu)
DK (1) DK0776199T3 (hu)
ES (1) ES2139932T3 (hu)
FI (1) FI118720B (hu)
GR (1) GR3032218T3 (hu)
HU (1) HU226959B1 (hu)
IL (1) IL114949A (hu)
MX (1) MX9701302A (hu)
NO (1) NO313984B1 (hu)
NZ (1) NZ291813A (hu)
PL (1) PL180965B1 (hu)
SK (1) SK281626B6 (hu)
WO (1) WO1996005814A1 (hu)
ZA (1) ZA956925B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
US10493049B2 (en) 2016-02-10 2019-12-03 Niracle LLC Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
CN117545474A (zh) 2021-11-08 2024-02-09 李维庸 一种用于向患者递送药物的透皮给药系统

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12731T1 (de) * 1979-01-11 1985-05-15 Key Pharma Polymere diffusionsmatrix und verfahren zu deren herstellung.
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
CA1163559A (en) * 1980-07-09 1984-03-13 Alec D. Keith Polymeric diffusion matrix for administration of drugs
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
ZA853488B (en) * 1984-05-10 1986-12-30 American Home Prod Transdermal dosage form
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
DD279818A1 (de) * 1989-02-06 1990-06-20 Jenapharm Veb Verfahren zur herstellung eines medizinischen pflasters
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
WO1993025168A1 (en) * 1992-06-11 1993-12-23 Theratech, Inc. The use of glycerin in moderating transdermal drug delivery
US5683711A (en) * 1993-04-20 1997-11-04 Hexal Pharma Gmbh Active ingredient patch

Also Published As

Publication number Publication date
IL114949A (en) 1998-12-27
SK22097A3 (en) 1997-07-09
NO970360D0 (no) 1997-01-28
IL114949A0 (en) 1995-12-08
US5902602A (en) 1999-05-11
DK0776199T3 (da) 2000-04-10
KR100401136B1 (ko) 2004-03-31
DE4429667C2 (de) 1996-07-11
JP3825799B2 (ja) 2006-09-27
FI118720B (fi) 2008-02-29
PL180965B1 (pl) 2001-05-31
CN1078461C (zh) 2002-01-30
NZ291813A (en) 1998-01-26
HU226959B1 (en) 2010-03-29
GR3032218T3 (en) 2000-04-27
DE4429667A1 (de) 1996-02-22
FI970701A (fi) 1997-02-19
AU695970B2 (en) 1998-08-27
DE59506962D1 (de) 1999-11-04
KR970705381A (ko) 1997-10-09
NO970360L (no) 1997-01-28
CZ289397B6 (cs) 2002-01-16
CN1155835A (zh) 1997-07-30
NO313984B1 (no) 2003-01-13
CZ50997A3 (en) 1997-06-11
WO1996005814A1 (de) 1996-02-29
EP0776199A1 (de) 1997-06-04
EP0776199B1 (de) 1999-09-29
JPH10504313A (ja) 1998-04-28
PL319013A1 (en) 1997-07-21
ZA956925B (en) 1996-03-25
ES2139932T3 (es) 2000-02-16
MX9701302A (es) 1998-05-31
SK281626B6 (sk) 2001-05-10
AU3344995A (en) 1996-03-14
FI970701A0 (fi) 1997-02-19
ATE185067T1 (de) 1999-10-15

Similar Documents

Publication Publication Date Title
YU48549B (sh) Postupak za izradu transdermalnog terapijskog sistema sa aktivnom materijom tulobuterolom
PT739199E (pt) Adesivo de estradiol com agente reforcador da penetracao
ZA947240B (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid
IL106315A0 (en) Transdermal therapeutic system containing 17beta-estradiol
HUT77085A (hu) Ösztradioltartalmú transzdermális terápiás rendszer TTS vízmegkötő adalékokkal és eljárás előállítására
IL114948A0 (en) A transdermal therapeutic system containing estradiol and a process for the preparation thereof
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives
EE03135B1 (et) Transdermaalne terapeutiline süsteem füsostigmiini manustamiseks ja meetod selle valmistamiseks

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees